Xiangling Chu

Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

Xiangling Chu, Jing Zhao, Juan Zhou et al. · Lung Cancer · 2020 · 141 citations

Life Sciences, Immunology, Oncology +17

Epidermal growth factor receptor tyrosine kinase inhibitor remodels tumor microenvironment by upregulating LAG-3 in advanced non-small-cell lung cancer

Juan Zhou, Xin Yu, Likun Hou et al. · Lung Cancer · 2021 · 38 citations

Medicine, Cancer Biology, Oncology +12

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

Juan Zhou, Chao Zhao, Jing Zhao et al. · Thoracic Cancer · 2019 · 32 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

Juan Zhou, Jing Zhao, Qingzhu Jia et al. · Frontiers in Oncology · 2021 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram

Xiaohui Jia, Xiangling Chu, Lili Jiang et al. · Lung Cancer · 2022 · 22 citations

Medicine, Oncology, Pharmacology +13